World stocks ring in new year with record highs
Send a link to a friend
[January 04, 2021]
By Ritvik Carvalho
LONDON (Reuters) -World stock markets hit
record highs on Monday, the first trading day of the new year, as
investors hoped the rollout of vaccines would ultimately lift a global
economy decimated by the COVID-19 pandemic.
The Chinese yuan surged nearly 1% against the dollar, while the
greenback plumbed its lowest levels against a basket of peer currencies
since April 2018. Bitcoin took a 10% dive, falling below $30,000 after a
blistering 800% rally since mid-March last year.
By 1126 GMT, European stock indexes were all higher, with Britain's FTSE
100 gaining 2.76%, Germany's DAX up 1.3%, Spain's IBEX up 1.36% and
Italy's FTSE MIB rising 1%. The pan-European STOXX 600 index was on
course for its best day since Nov. 9, up 1.6%. [.EU]
E-Mini futures for the S&P 500 were up 0.6%, after also touching a
record high. [.N]
MSCI's All-Country World Index, which tracks stocks across 49 countries,
hit a record high and was up 0.6% on the day.
"The year kicks off as 2020 ended, an everything rally with the double V
dichotomy (virus vs. vaccine) seeing the hopes that either things get
worse and stimulus ramps up or things get better and, well, things get
better so long as there’s no hint of liquidity withdrawal and a taper
tantrum," a trader said.
Asian stock markets also gained, although Japan's Nikkei 225 index shed
early gains, falling 0.4% after Prime Minister Yoshihide Suga confirmed
the government was considering a state of emergency for Tokyo and three
surrounding prefectures as the coronavirus spreads.
Despite the optimism over vaccines, investors are still sounding caution
over the path of the virus, which continues to spread amidst the
discovery of a new strain.
"The virus retains the upper hand for a while longer," said Karl
Steiner, chief quantitative strategist at SEB, noting that vaccinations
have had an uneven start, characterized by vaccine shortages, vaccine
resistance and delays.
Britain began vaccinating its population with the COVID-19 shot
developed by Oxford University and AstraZeneca on Monday.
With the lag between a full vaccine rollout and a global economic
recovery, investors will count on central banks to keep money cheap.
"We continue to believe that equities have further room to rise in 2021
as monetary and fiscal stimulus measures provide a tailwind, and we
anticipate significant earnings growth as the global economy recovers,"
said Mark Haefele, chief investment officer at UBS Global Wealth
Management.
Minutes of the Federal Reserve's December meeting are due on Wednesday
and should offer more detail on discussions about making their forward
policy guidance more explicit and the chance of a further increase in
asset buying this year.
[to top of second column]
|
Traders work at the Frankfurt's stock exchange, amid the coronavirus
disease (COVID-19) outbreak, in Frankfurt, Germany, December 30,
2020. REUTERS/Ralph Orlowski
EYES ON DATA
The data calendar includes a raft of manufacturing surveys across
the globe, which will show how industry is coping with the spread of
the coronavirus, and the closely watched ISM surveys of U.S.
factories and services.
Chinese factory activity continued to accelerate in December, though
the PMI missed forecasts.
Japanese manufacturing stabilised for the first time in two years in
December, while Taiwan picked up.
Friday sees the U.S. December payroll report where median forecasts
are for only a modest increase of 100,000 jobs.
Analysts as Barclays are tipping a fall of 50,000 in jobs, which
would be a shock to market hopes of a speedy recovery.
"A number of incoming indicators on activity point to slower
momentum as the economy closes out the year, including data on
labour markets where initial claims rose during the December survey
period," said economist Michael Gapen in a note.
Such a drop would add pressure on the Fed to ease further, another
burden for the dollar which is already buckling under the weight of
the massive U.S. budget and trade deficits.
In currencies, the euro pushed back up to $1.2294, having run into
profit-taking late last week when it reached the highest since early
2018 at $1.2309. It gained almost 9% over 2020.
The dollar slipped to 102.80 yen. Sterling firmed to $1.3690, levels
last seen in mid-2018.
The decline in the dollar has been a support for gold, leaving the
metal 1.3% firmer at $1,931 an ounce.
Oil prices extended their rise after a couple of months of solid
gains, with Brent crossing $53 a barrel. [O/R] U.S. crude added 1%
to $49 a barrel.
(Reporting by Ritvik Carvalho; additional reporting by Carolyn Cohn
in London and Wayne Cole in Sydney; Editing by Toby Chopra)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |